Esophageal Disease
Conditions
Interventions
experimental group:conduct artificial pneumothorax
control group:do not conduct artificial pneumothorax
Sponsors
Thoracic Surgery Department, West China Hospital, Sichuan University
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: (1) patients aged 18 to 80 years; (2) patients with thoracic esophageal cancer who have preoperative and postoperative pathological reports confirming it is a malignant tumor; (3) patients did not accepted neoadjuvant radiotherapy and chemotherapy before surgery; (4) patients without other malignant tumors; (5) sign informed consent form and willing to attend this study.
Exclusion criteria
Exclusion criteria: (1) patients receiving neoadjuvant radiotherapy and chemotherapy before operation; (2) patients with carcinoma of cardia and cervical esophagus; (3) patients with distant metastasis; (4) patients with poor heart, lung, liver and kidney functions and cannot tolerate the surgery; (5) patients who do not receive circulating tumor cell testing.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The number of circulating tumor cells before and after operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Recurrence and metastasis of tumors during 3-year follow-up;Operation duration;Postoperative complications, including anastomotic leakage, pneumonia, atelectasis, pulmonary edema, chylothorax, etc.;Overall survival; | — |
Countries
China
Contacts
Public ContactFeng Lin
West China Hospital, Sichuan University
Outcome results
None listed